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Abstract
Background: The genetic code consists of non-random usage of synonymous codons for the same amino acids,
termed codon bias or codon usage. Codon juxtaposition is also non-random, referred to as codon context bias or
codon pair bias. The codon and codon pair bias vary among different organisms, as well as with viruses. Reasons
for these differences are not completely understood. For classical swine fever virus (CSFV), it was suggested that
the synonymous codon usage does not significantly influence virulence, but the relationship between variations in
codon pair usage and CSFV virulence is unknown. Virulence can be related to the fitness of a virus: Differences in
codon pair usage influence genome translation efficiency, which may in turn relate to the fitness of a virus.
Accordingly, the potential of the codon pair bias for clustering CSFV isolates into classes of different virulence was
investigated.
Results: The complete genomic sequences encoding the viral polyprotein of 52 different CSFV isolates were
analyzed. This included 49 sequences from the GenBank database (NCBI) and three newly sequenced genomes.
The codon usage did not differ among isolates of different virulence or genotype. In contrast, a clustering of
isolates based on their codon pair bias was observed, clearly discriminating highly virulent isolates and vaccine
strains on one side from moderately virulent strains on the other side. However, phylogenetic trees based on the
codon pair bias and on the primary nucleotide sequence resulted in a very similar genotype distribution.
Conclusion: Clustering of CSFV genomes based on their codon pair bias correlate with the genotype rather than
with the virulence of the isolates.
Background
Classical swine fever (CSF) is a serious and highly conta-
gious disease of pigs that can cause important econom-
ical losses in the pig industries [1,2]. The disease is
caused by the classical swine fever virus (CSFV), cur-
rently endemic in wild boars and in part also in domes-
tic pigs in Asia, South America, and parts of Central
and Eastern Europe [1,3,4]. Depending on the isolate,
the disease can vary from an acute hemorrhagic fever to
a chronic or unapparent infection. An acute infection
w i t hah i g h l yv i r u l e n ts t r a i n manifests with high fever,
respiratory and gastrointestinal symptoms, multiple hae-
morrhages, neurological disorders, and a high mortality
rate [5]. Chronic infections may not be immediately
recognized due to the mild symptoms. Infections with
low virulent isolates can remain unapparent. Thus CSFV
viruses are divided into strains of highly, moderately,
and low to avirulent strains (mainly vaccine strains)
[6,7], see also Table 1 with the references therein. A
number of live attenuated vaccines are available. These
vaccines are mostly based on the Chinese vaccine strain
(C-strain) and are completely avirulent [8-10].
CSFV is classified within the genus Pestivirus of the
family Flaviviridae together with Border disease virus
(BDV) and Bovine viral diarrhoea virus (BVDV) [33].
Pestiviruses possess a single-stranded positive-sense
RNA genome of approximately 12300 nucleotides, with
5’-terminal and 3’-terminal non-translated regions (5’-
NTR, 3’-NTR) [34]. The genome encodes one polypro-
tein that is co- and post-translationally processed by the
viral proteases N
pro, NS2, NS3, and by cellular proteases
[34]. The polyprotein is cleaved in the four structural
proteins C, E
rns, E1, E2, and in the eight non-structural
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any medium, provided the original work is properly cited.Table 1 Overview of the CSFV strains used for this study.
Isolate Genotype Virulence status GenBank (NCBI) entry Reference
ALD D49532 hv 1.1 hv D49532 [11]
Alfort187 × 87939 hv 1.1 hv X87939 [12]
AlfortA19 U90951 hv 1.1 hv U90951 [13]
Brescia AF091661 hv 1.2 hv AF091661 [14]
Brescia M31768 lv
1 1.2 hv M31768 [14]
BRESCIAX AY578687 hv 1.2 hv AY578687 [13]
CAP X96550 lv
2 1.1 Low virulent X96550 [15]
cF114 AF333000 hv 1.1 hv AF333000 [16]
Eystrup AF326963 hv 1.1 hv AF326963 [17]
Eystrup NC_002657 hv 1.1 hv NC_002657 [17]
Glentorf U45478 lv
3 1.1 Low virulent U45478 [18]
JL106 EU497410 hv 1.1 hv EU497410 [19]
Koslov HM237795 hv 1.1 hv HM237795 [19]
Shimen AF092448 hv 1.1 hv AF092448 unpublished
Shimen-HVRI AY775178 hv 1.1 hv AY775178 [19]
SWH DQ127910 hv 1.1 hv DQ127910 [6]
C_strain AY259122 va 1.1 va AY259122 [17]
C_strain AY382481 va 1.1 va AY382481 unpublished
C_strain AY663656 va 1.1 va AY663656 unpublished
C_strain C-ZJ-2008 va 1.1 va HM175885 unpublished
C_strain HCLV AF531433 va 1.1 va AF531433 unpublished
C_strain HVRI AY805221 va 1.1 va AY805221 unpublished
C_strain U45477 va 1.1 va U45477 unpublished
C_strain Z46258 va 1.1 va Z46258 [20]
flc-LOM EU915211 va 1.1 va EU915211
GPE- D49533 va 1.1 va D49533 [11]
HCLV AF091507 va 1.1 va AF091507 [21]
India vaccine EU857642 va 1.1 va EU857642 unpublished
LOM EU789580 va 1.1 va EU789580 [22]
LPC AF352565 va 1.1 va AF352565 [23]
RUCSFPLUM AY578688 va 1.2 va AY578688 [13]
Thiverval EU490425 va 1.1 va EU490425 [24]
944IL94TWN AY646427 mv 3.4 mv AY646427 [25]
Alfort-Tuebingen J04358 mv 2.3 mv J04358 [26]
Borken GU233731 mv 2.3 mv GU233731 [3]
CSF 39 AF407339 mv
4 recombinant mv-hv AF407339 [27]
Euskirchen GU233732 mv 2.3 mv GU233732 [3]
GXW_Z02 AY367767 mv 2.1 mv AY367767 [27]
Hennef GU233733 mv 2.3 mv GU233733 [3]
Jambul CSF0864 mv 2.3 mv HQ148062 [28]
Novska CSF0821 mv 2.3 mv HQ148061 [28]
Paderborn GQ902941 mv 2.1 mv GQ902941 [29,30]
Penevezys CSF1048 mv 2.1 mv HQ148063 [28]
Roesrath GU233734mv 2.3 mv GU233734 [3]
Sp01 FJ265020 mv 2.3 mv FJ265020 unpublished
Uelzen GU324242 mv 2.3 mv GU324242 [3]
96TD AY554397 uk 2.1 uk AY554397 unpublished
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pro, p7, NS2, NS3, NS4A, NS4B, NS5A, and
NS5B [35-37].
By phylogenetic classification, the CSFV strains are
divided into the three different genotypes 1, 2, and 3,
every genotype consisting of three to four subgenotypes
[38]. The most recent CSFV outbreaks in the European
Community are associated essentially with isolates that
cluster in the genotype 2. In general, the genotype 2 iso-
lates are of moderate or low virulence, as are the isolates
of genotype 3 [3,4,39]. To the best of our knowledge,
the CSFV strains with the highest virulence identified so
far all belong to genotype 1. However, there is no abso-
lute relationship between genotype and virulence, as
there are also low virulent field isolates (e.g. “Glentorf”)
of genotype 1, and isolates within the genotype 2 group
(e.g. “Uelzen”) for which infection of piglets results in
higher mortality than with most genotype 2 isolates. In
addition, all vaccine strains belong also to genotype 1, as
they were derived from genotype 1 strains by attenua-
tion through multiple passages in non natural hosts,
typically rabbits and guinea pigs, or in cell cultures
derived from them.
Various experimental approaches were implemented
with the aim of identifying the virulence determinants
related to a particular CSFV isolate. Numerous mutants
with deletions, insertions, peptide or amino acid
exchanges were analyzed and described in detail [40-46].
All mutants described so far were attenuated, leading to
the conclusions that the modified positions may be rele-
vant for the virulence of a specific strain or of CSFV in
general. Certainly, strain-specific virulence factors deter-
mine whether an infection results in acute hemorrhagic
fever, chronic disease or subclinical infection. Whether
virulence determinants can be associated with particular
amino acid positions remains unanswered. From a gen-
eral point of view however, one may speculate that viru-
lence depends mostly on the speed and level of virus
replication. For poliovirus and influenza virus it was
shown that the codon pair bias can influence fitness and
virulence [47,48]. The codon pair bias refers to the non
random juxtaposition of codons, while the non random
usage of synonymous codons for the same amino acids
is referred to as codon bias. Previous studies showed
that differences in synonymous codon usage did not
relate to the virulence of CSFV isolates [7]. There is no
analysis of codon pair usage of CSFV available. There-
fore, the aim of this study was to investigate whether
the codon pair usage of CSFV may relate to virulence or
simply cluster the isolates into their genotype.
Results
Sequencing of complete genomes of recent CSFV isolates
In order to include some of the latest European CSFV iso-
lates in the codon pair bias analysis, the genome of three
recent field isolates were sequenced. The complete nucleo-
tide sequences of the isolates CSFV/2.3/dp/CSF0821/
2002/HR/Novska, CSFV/2.3/dp/CSF864/2007/BG/Jambul,
and CSFV/2.1/dp/CSF1048/2009/LT/Penevezys were
deposited to the NCBI GenBank nucleotide database
[GenBank: HQ148061-HQ148063]. The genomes of the
newly sequenced isolates encode a polyprotein of 3898
amino acids. The 5’NTRs of the three isolates are 373
nucleotides long. The 3’NTR is composed of 225 nucleo-
tides for the “Novska” isolate and of 226 nucleotides for
the two other isolates. These three sequences were
included in a phylogenetic tree together with 49 complete
CSFV genome sequences obtained from GenBank (Figure
1). The three newly sequenced isolates belong to the geno-
type 2, with the isolates “Novska” and “Jambul” clustering
with the subgenotype 2.3 strains and the isolate “Peneve-
zys” belonging to subgenotype 2.1. With experimental
infections of pigs, the isolate “Penevezys” was classified as
low to moderately virulent whereas the two other isolates
were moderately virulent. Detailed information on the
genotype, virulence, and origin of the 52 CSFV isolates
analysed are provided in Table 1.
Table 1 Overview of the CSFV strains used for this study. (Continued)
0406CH01TWN AY568569 uk 2.1 uk AY568569 unpublished
HEBZ GU592790 uk 2.1 uk GU592790 unpublished
SXCDK GQ923951 uk 2.1 uk GQ923951 unpublished
SXYL2006 GQ122383 uk 2.1 uk GQ122383 unpublished
ZJ0801 FJ529205 uk 2.1 uk FJ529205 unpublished
Virulence status: highly virulent (hv), moderately virulent (mv), low virulent (lv) or vaccine strains (va), and unknown virulence (uk) is indicated according to the
information available. If available, the references to the sequences are indicated.
1 Brescia M31768 lv
1 is representing the sequence of strain Brescia C1.1.1 which is a low virulent strain obtained after the 30
th passage of strain Brescia on PK-15
cells [31].
2 CAP X96550 lv
2 is described as highly virulent strain in some publications, but was originally described as cell culture adapted strain of low virulence [15].
3 Glentorf U45478 lv
3 is described as low virulent or as highly virulent strain, depending on the report. In this study it is considered to be low virulent according
to the publication of Handel et al. and Ahrens et al. [18,32]
4 CSF 39 AF407339 mv
4 is a recombinant CSFV from China [27]. The virulence of this strain cannot be related to a particular genotype because the 5’NTR and the
3’NTR as well as the NS5A/B genes are homologous to genotype 1.1 strains, while the structural genes are homologous to genotype 2.1 strains. Furthermore the
sequence of the original isolate is not known since the 32
nd cell culture passage was used for sequence analysis.
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vary among different CSFV isolates
In order to determine the variations in RSCU between
CSFV isolates of different genotypes and virulence, the
frequency of each codon was determined for the 52
complete genome sequences available. As an example,
the codon usage of three prototype isolates of different
virulence, the low virulent “Glentorf” strain, the highly
 cF114 AF333000 hv pp
 Shimen AF092448 hv pp
 JL106 EU497410 hv pp
 Shimen-HVRI AY775178 hv pp
 SWH DQ127910 hv pp
 CAP X96550 hv pp
 Glentorf U45478 hv pp
 GPE- D49533 va pp
 flc-LOM EU915211 va pp
 LOM EU789580 va pp
 Thiverval EU490425 va pp
 Alfort187 X87939 hv pp
 AlfortA19 U90951 hv pp
 ALD D49532 hv pp
 Koslov HM237795 hv pp
 Eystrup AF326963 hv pp
 Eystrup NC 002657 hv pp
 India vaccine EU857642 va pp
 C strain AY259122 va pp
 C strain U45477 va pp
 C strain Z46258 va pp
 HCLV AF091507 va pp
 C strain AY663656 va pp
 C strain AY382481 va pp
 C strain C-ZJ-2008 va pp
 C strain HCLV AF531433 va pp
 C strain HVRI AY805221 va pp
 Brescia AF091661 hv pp
 RUCSFPLUM AY578688 va pp
 Brescia M31768 hv pp
 BRESCIAX AY578687 hv pp
 CSF 39 AF407339 mv pp
 Hennef GU233733 mv pp
 Roesrath GU233734mv pp
 Euskirchen GU233732 mv pp
 Borken GU233731 mv pp
 Sp01 FJ265020 mv pp
 Alfort-Tuebingen J04358 mv pp
 Jambul CSF0864 mv pp
 Uelzen GU324242 mv pp
 Novska CSF0821 mv pp
 96TD AY554397 uk pp
 SXCDK GQ923951 uk pp
 Paderborn GQ902941 mv pp
 GXW Z02 AY367767 mv pp
 Penevezys CSF1048 mv pp
 SXYL2006 GQ122383 uk pp
 HEBZ GU592790 uk pp
 0406CH01TWN AY568569 uk pp
 ZJ0801 FJ529205 uk pp
 944IL94TWN AY646427 mv pp
 LPC AF352565 va pp  
Genotype 1 
Genotype 1.2 
Genotype 2.3
Genotype 2.1
Genotype 3.4 
Genotype 1 
Recombinant 
Figure 1 Phylogenetic tree representing 52 complete CSFV polyprotein encoding nucleotide sequences. The tree was built using the
MEGA4 software.
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Page 4 of 11virulent “Koslov” strain, and the moderately virulent
“Euskirchen” isolate is shown in Figure 2A-C . All
three virus isolates have a very similar RSCU pattern.
The two codons encoding the amino acid lysine (AAA
a n dA A G )a r et h em o s tf r e q u e n tc o d o n sa p p e a r i n gi n
the CSFV genomes. The AAG triplet is slightly pre-
ferred. AAA is found in average 142,4 times/polypro-
tein with a standard deviation of 3.8 whereas AAG is
found in average 151,6 times/polyprotein with a stan-
dard deviation of 3.6, independently of genotype and
virulence. For the amino acid arginine there is a total
of six different codons possible: CGA, CGC, CGG,
CGU, AGA, and AGG. The four codons CGA, CGC,
CGG, CGU are amongst the rarest codons used in all
isolates. Thus, arginine is encoded almost exclusively
by AGA and AGG, but here again, no major differ-
ences between strains of different virulence can be
observed. Overall, no significant differences were
observed between the different isolates confirming
earlier results showing that the RSCU does not vary
between strains of different virulence [7].
The codon pair bias clusters CSFV into groups of different
genotypes
Since the analysis of RSCU did not reveal any obvious
differences among isolates of different virulence, it was
of interest to determine whether the codon pair usage
differs between CSFV isolates. To this end, the ANA-
CONDA 2.0 software was applied to analyse the codon
pair bias of the polyprotein encoding sequences of the
52 CSFV isolates. As opposed to the RSCU, clear differ-
ences were observed between different isolates (Figure
3). The codon pair analysis clustered the isolates in two
groups, one representing the avirulent and the highly
virulent strains, and the other the moderately virulent
strains. The codon pairs CAA-AGA and GCA-GGG for
instance are preferred by moderately virulent strains,
but strongly rejected among vaccine viruses and highly
A   Glentorf [GenBank:U45478] 
 
B   Koslov [GenBank:HM237795] 
 
C   Euskirchen [GenBank:GU233732] 
 
Figure 2 Relative synonymous codon usage exemplified with three prototype CSFV isolates. The histograms show the frequencies of
synonymous codon usage in per mille for the strains “Glentorf” [GenBank:U45478], “Koslov” [GenBank:HM237795], and “Euskirchen” [GenBank:
GU233732]. The values were calculated using the ANACONDA 2.0 software.
Leifer et al. BMC Research Notes 2011, 4:521
http://www.biomedcentral.com/1756-0500/4/521
Page 5 of 11virulent strains. On the other hand, the pairs UAC-
GGU, UAC-GAU, AGA-CUA, and GCA-GAA are pre-
ferred by vaccine and highly virulent viruses and are
rejected by moderately virulent strains. Remarkably, the
codon pairs with the pattern UAC-GGN and UAC-
GAN strongly rejected among moderately virulent
strains. Pairwise comparison of the complete codon pair
context maps of vaccine strains among each other, and
those of vaccine and highly virulent strains revealed
similar degrees of variability (exemplified in Figure 4A-
D). Interestingly, the diversity within the group of vac-
cine strains is in some cases higher compared to the
diversity between vaccine strains and highly virulent
strains (Figure 4A-D).
It was also hypothesised that the codon pair bias may
affect specifically the genome replication efficiency. In
Codon pair          Vaccine strains           Moderate virulent strains       High virulent strains 
 
 
 
 
 
Figure 3 The codon pair usage clusters CSFV strains into their different genotypes. Parts of a codon pair context map alignment of 46
different CSFV isolates with known virulence status are shown. The virus isolates are divided into vaccine strains, moderately virulent strains, and
highly virulent strains. The frequencies of codon pair usage are represented by different colours. Green indicates that codon pairs are strongly
preferred. Red indicates that codon pairs are rejected. Black means that there is no significant difference in codon pair usage. The values were
calculated using the ANACONDA 2.0 software.
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Page 6 of 11order to determine whether the codon pair bias differs
between the replicase and the structural proteins,
which would suggest a potential effect of the codon
pair bias on replication efficiency and virulence, artifi-
cial open reading frames ORFs were constructed cov-
ering the structural proteins and the NS5B protein of
each CSFV strain. These ORFs were compared with
respect to codon pair usage. No obvious differences in
codon pair usage between structural and replicase
genes were found, irrespectively of genotype and viru-
lence (data not shown). Therefore, analysis of the indi-
vidual genes did not allow discrimination between
virulence either.
Finally, a phylogenetic tree based on the codon pair
usage of the complete polyprotein encoding nucleotide
sequences of the 52 isolates was constructed using the
ANACONDA 2.0 software (Figure 5). The codon pair
usage clusters the isolates in genotypes 1, 2, 3, and sub-
genotypes 2.1 and 2.3, similarly to the phylogenetic tree
based on the primary nucleotide sequence (compare Fig-
ures 1 and 5). Interestingly, some vaccine strains are
grouped with the highly virulent strains, e. g. the strains
“Alfort” and “Thiverval”. According to these data, the
codon pair bias clusters the CSFV isolates by genotype
rather than by virulence.
Discussion
Despite numerous efforts, CSFV virulence could not be
linked to any particular genome sequence signature so
far. Most if not all highly virulent CSFV strains belong
to genotype 1 as do the vaccine strains (Table 1 and the
references listed therein). Moderately virulent strains
belong essentially to genotypes 2 and 3. The genetic
variability within the genotype 1 is lower compared to
strains of genotype 2 and 3 [49,50]. This lets hypothe-
size that sequence signatures of virulence may be found,
especially with full sequence data of vaccine strains and
parental highly virulent strains [51].
From the functional point of view, virulence may
depend on viral replication efficiency, which can be
influenced by differences in protein expression. Codon
and codon pair bias can have an impact on translation
efficiency and protein expression as it was shown for
bacteria and yeast [52,53]. For poliovirus and influenza
A virus, the artificial use of rare codons and of underre-
presented codon pairs reduced viral protein translation
and viral fitness, resulting in virus attenuation in vivo
[47,48]. Consequently, a potential influence of codon
usage and in particular of codon pair usage on CSFV
virulence was considered. The analysis of the RSCU of
52 virus isolates covering the whole spectrum of viru-
lence did not reveal any relationship with virulence.
This confirmed earlier results obtained with the com-
plete genome sequences of 35 isolates [7]. Thus codon
usage between CSFV isolates is very similar, which is in
agreement with the findings that RNA viruses of the
same host category have the same codon usage prefer-
ences [54]. For the human immunodeficiency virus type-
1, the RSCU is different from that of the human host.
Adaptation towards human RSCU was attributed to the
homogenization of the codon usage by mutation pres-
sure rather than host adaptation [55].
Analysis of the codon pair bias of the complete coding
sequence of the 52 isolates revealed a clear clustering
(Figure 3). Vaccine strains and highly virulent strains
showed mostly the same pattern, differing from the
codon pair usage of moderately virulent strains. Because
highly virulent and vaccine strains belong to genotype 1
and moderately virulent strains belong essentially to
genotype 2, similarities in codon pair usage within a
genotype might be due to the high proportion of
sequence identity. Indeed, the genotype clustering
obtained with phylogenetic analysis based on the codon
pair usage and on the primary nucleotide sequence was
nearly identical (compare Figures 5 and 1). Nevertheless,
t h i sd o e sn o te x c l u d eap o s s i b l er e l a t i o n s h i po ft h e
Figure 4 Codon pair bias overlays of vaccine and highly virulent CSFV strains using the differential display codon pair context tool of
ANACONDA 2.0; 61 × 64 codon pair bias matrices are shown. Yellow spots indicate differences in the corresponding codon pair usage
whereas black colour means that codon pairs are used with similar residual values. Shown are codon pair overlays of the “GPE
-“ vaccine strain
and the parental highly virulent “ALD” strain (A), of the highly virulent “ALD” and “Koslov” strains (B), of the “GPE
-“ and “C-strain Riems” vaccine
viruses (C), and of the “C-strain Riems” and “HCLV” vaccine viruses (D).
Leifer et al. BMC Research Notes 2011, 4:521
http://www.biomedcentral.com/1756-0500/4/521
Page 7 of 11codon pair usage with the virulence phenotype. The codon
pair UAC-GNN for instance is less preferred by CSFV
strains of genotype 2. Cytosin-phosphatidyl-Guanin (CpG)
dinucleotides are signals for DNA methylation in
eukaryotes and regulate gene expression [56,57]. A reduc-
tion of UAC-GNN codon pair usage could reflect a host-
specific adaption, as it might influence the host anti-viral
response as described for other viruses [58,59]. For CSFV
Genotype 1 
Genotype 1.2 
Genotype 2.3 
Genotype 3.4 
Recombinant 
Genotype 2.1 
Figure 5 Phylogenetic tree of the CSFV polyprotein sequence alignment of 52 different isolates based on their codon pair bias, for
analysis the ANACONDA 2.0 software was used.
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Page 8 of 11it is unknown whether adaptation to the host is linked to a
gain of viral fitness. One could hypothesize that highly
virulent CSFV strains would emerge through increased
viral replication in the host. However, adaptation to the
host is likely to result in optimized rather than in
enhanced replication since occurrence of higher virulent
strains has not been observed in CSFV field isolates during
the last years [3,4,39,60]. From the evolutionary point of
view, natural selection or adaptation towards a moderately
virulent strain makes sense, because the mortality of the
host is lower [39,60,61]. In addition, failure in early diag-
nosis due to mild clinical symptoms contributes to the dis-
semination and survival of the virus [59]. Thus, a
moderately or low virulent virus has a greater chance of
circulating in a pig or wild boar population without being
detected [62-64]. Hence the reduced virulence observed
with the CSFV isolates from the more recent outbreaks in
Europe could result from several driving forces represent-
ing advantages for the virus. In fact, during the last dec-
ades CSFV outbreaks in Europe and Asia were
increasingly caused by genotype 2 and 3 isolates, while the
older CSFV field isolates belong to genotype 1. This sug-
gests that evolution of CSFV is directed towards genotype
2 and 3. However, it is unknown if this is applicable to
South American isolates since sequence information is
missing. The development of live attenuated CSFV vaccine
strains was based on isolates belonging to the genotype 1,
which explains the close phylogenetic relationship between
highly virulent and vaccine strains within the same geno-
type. Interestingly, there are nevertheless obvious differ-
ences in codon pair usage among strains of genotype 1 as
seen from the overlays of codon pair matrices. These dif-
ferences are the most prominent between the two unre-
lated “GPE
-” and “C-strain” vaccine strains attenuated in
guinea pigs and rabbits, respectively. It is likely that these
differences are in part caused by the propagation of the
viruses in different hosts.
Conclusions
The present results describet h ef i r s te x t e n s i v ec o d o n
pair bias analysis of a representative number of CSFV
isolates covering the complete spectrum of virulence.
Overall, the CSFV strains can be grouped in two main
clusters according to the codon pair usage. Thus codon
pair bias analysis can support CSFV phylogeny. How-
ever, based on the data presented here, a direct link
between the codon pair usage and CSFV virulence can-
not be established.
Methods
Sequencing of complete CSFV genomes
Nucleotide sequence analysis of complete CSFV genome
was performed by pyrosequencing with a FLX Genome
Sequencer (Roche Diagnostics, Mannheim, Germany) as
described previously [3]. Briefly, full CSFV genome
DNA fragments (obtained by long-range RT-PCR) were
separated by agarose gel electrophoresis and purified
using the Zymoclean™ Gel DNA Recovery Kit (Zymo
Research Corporation, Orange, CA, USA) prior to analy-
sis with the FLX Genome Sequencer. The 5’NTR and
3’NTR were sequenced using commercial kits for RACE
RT-PCR (5’RACE System and 3’RACE System, Invitro-
gen, Carlsbad, CA, USA) according to the manufacturers
recommendations. Minor modifications were performed
as described previously [3]. The raw sequence data were
assembled using the GS assembler software newbler (v.
2.0.00.22; Roche, Mannheim). The nucleotide sequence
information was deposited to the NCBI GenBank
nucleotide database [65].
Sequence data source and additional sequence
information
Complete genome sequences of 49 different CSFV iso-
lates were obtained from the NCBI GenBank nucleotide
database. Detailed information on the virus isolates is
provided in Table 1. Virus isolates were grouped in
highly virulent (hv), moderately virulent (mv), and low
virulent (lv) or vaccine strains (va). According to the
information available, 46 virus isolates were subdivided
into these three groups composed of 16 highly virulent,
14 moderately virulent, and 16 vaccine strains (Table 1).
For the remaining virus isolates virulence could not be
determined.
Analysis of RSCU and codon pair usage
The relative synonymous codon usage is expressed as
RSCU value of a codon [53]. The RSCU value expresses
the relationship between the observed and the expected
codon frequency and was calculated with the ANA-
CONDA 2.0 software (Universidade de Aveiro, Portugal)
[66]. The codon context bias of the complete polypro-
tein encoding nucleotide sequence of 52 different CSFV
isolates was investigated using the software package
ANACONDA 2.0 as described [67-69]. In addition, dif-
ferent regions of the genomes were analysed separately.
To this end, artificial ORFs for the NS5B and the struc-
tural protein genes were constructed by adding a start
and stop codon to the corresponding coding regions.
Codon pair biases were analysed according to their rela-
tive occurrence. Statistical calculation of the codon pairs
is given in relation to its real occurrence and the
expected incidence independently of their distribution.
The ANACONDA 2.0 software displays a codon pair
context map for each viral ORF. This context map con-
sists of 3904 possible codon pairs given in a vertical raw
with one coloured square for each codon pair. The col-
ours represent the frequency of occurrence: red
coloured squares indicate codon pairs that are strongly
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Page 9 of 11rejected, whereas preferred codon pairs are represented
in green colour. Codon pairs represented by black
squares are statistically not significant.
Phylogenetic trees based on codon pair bias were cre-
ated with the ANACONDA 2.0 software. Neighbour-
joining trees with the maximum composite likelihood
method using complete polyprotein encoding nucleotide
sequences were constructed with the MEGA4 software
(Molecular Evolutionary Genetics Analysis, Center for
Evolutionary Medicine and Informatics, Tempe, USA)
software [69].
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